FS Thx for clarifying that . I briefly asked if they were prescribing Auryxia in her dept . To her knowledge only 1 patient was on it as insurance providers demanded patient fail existing treatments first and required extensive paper work to enable a switch .
Will try and get more detail this evening . The 2 CKD drugs in development that her Dept seemed most interested in, are being developed by FGEN and OMER
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.